DIANA WESTBROOK: Open Payments
NPI 1215487780 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,307 in 55 payments from 14 companies in 2025. Trend: 2023 $1,282 · 2024 $2,283 · 2025 $1,307
Food & beverage: $1,307
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $260 |
| UCB, Inc. | 6 | $169 |
| Arcutis Biotherapeutics, Inc. | 7 | $151 |
| GENZYME CORPORATION | 3 | $140 |
| Galderma Laboratories, L.P. | 6 | $132 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| LEO Pharma Inc. | 4 | $94 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| PFIZER INC. | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $31 |
Products named: Bimzelx, Zoryve, DUPIXENT, NEMLUVIO, SKYRIZI, ADBRY, RINVOQ, LIBTAYO.
Industry payments across CA — which companies pay providers there.
